News Releases

Email Alerts

Feb 1, 2018

Sensus Healthcare Reports Record Revenue for 2017 Fourth Quarter and Full Year

Ninth consecutive quarter of double-digit year-over-year revenue growth

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT),...
Jan 25, 2018

Sensus Healthcare to Host Fourth Quarter and Fiscal Year 2017 Financial Results and Business Update Conference Call on February 1, 2018

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT),...
Jan 8, 2018

Sensus Healthcare Brings Superficial Radiation Therapy (SRT) to China for Keloid Prevention and Treatment

Sensus and Chindex Medical Begin Shipping SRT-100 Units to Treat Keloid Patients

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today...
Nov 2, 2017

Sensus Healthcare Reports Third Quarter Financial Results Featuring Revenue up 44%

Marks eighth consecutive quarter of double-digit year-over-year revenue growth

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT),...
Nov 1, 2017

Sensus Healthcare Launches SRT-100 in China for Keloid Prevention and Treatment at Major Dermatology Conference, Extends Distribution Agreement with Chindex Medical

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT),...

Show per page